"Centre administratif"

During the past decade, Centre integre universitaire de sante et de services sociaux du Saguenay-Lac-Saint-Jean conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 6 clinical trials were completed, i.e. on average, 31.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre integre universitaire de sante et de services sociaux du Saguenay-Lac-Saint-Jean" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Laurent Pharmaceuticals Inc." with 2 trials sponsored and "NRG Oncology" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre integre universitaire de sante et de services sociaux du Saguenay-Lac-Saint-Jean" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Cystic Fibrosis Foundation" with 2 trials as a collaborator, "Astellas Pharma Europe Ltd." with 1 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Centre integre universitaire de sante et de services sociaux du Saguenay-Lac-Saint-Jean" are "Cystic Fibrosis" (2 trials), "Stage II Prostate Adenocarcinoma" (2 trials), "Stroke" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Centre integre universitaire de sante et de services sociaux du Saguenay-Lac-Saint-Jean" in a lesser frequency.

Most popular intervention types in "Centre integre universitaire de sante et de services sociaux du Saguenay-Lac-Saint-Jean" are "Drug" (20 trials), "Radiation" (3 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials), "JNJ-78934804" (2 trials) and "LAU-7b" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre integre universitaire de sante et de services sociaux du Saguenay-Lac-Saint-Jean" are 20 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centre integre universitaire de sante et de services sociaux du Saguenay-Lac-Saint-Jean". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Centre integre universitaire de sante et de services sociaux du Saguenay-Lac-Saint-Jean, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre integre universitaire de sante et de services sociaux du Saguenay-Lac-Saint-Jean, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".